Abbott's Cologuard Plus Receives CE Mark for Colorectal Cancer Screening in Europe

Bitget2026/10/20 06:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Abbott's Cologuard Plus received CE Mark under EU medical device regulations for noninvasive colorectal cancer screening.
Launches are planned in select European markets, with timing and availability varying by country.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via PR Newswire (Ref. ID: EN75830) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abbott's Cologuard Plus Receives CE Mark for Colorectal Cancer Screening in Europe

You may also like

Crypto prices